Mind Medicine (MindMed) Inc expected to post a loss of 33 cents a share - Earnings Preview

Definium Therapeutics

30/07/2024 15:15

* Mind Medicine (MindMed) Inc  MNMD.OQ   MNMD.O  is expected
to show no change in quarterly revenue when it reports 
results on August 1 (estimated) for the period ending January
1 0001
    * 
    * ​LSEG's mean analyst estimate for Mind Medicine (MindMed)
Inc is
for a loss of 33 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Mind
Medicine
(MindMed) Inc is $21.00​, above​ its last closing price
of $9.10. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.56       -0.53      -1.14     Missed  -115.7
 Dec. 31 2024  -0.46       -0.46      -0.59     Missed  -27.5
 Jan. 1 0001   -0.68       -0.67      -0.45     Beat    33.3​
 Jun. 30 2023  -0.54       -0.54      -0.76     Missed  -41.6
 ​​Mar.        -0.42       -0.42      -0.52     Missed  -22.6
 31 2023                                                
 Jan. 1 0001   -0.56       -0.50      -0.16     Beat    68.2​
 Sep. 30 2022  -0.56       -0.60      -0.56     Beat    6
 Jun. 30 2022  -0.75       -0.75      -0.60     Beat    20
 This summary was machine generated July 30 at 14:15 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)